458 results
This deck gives programmatic and operational guidance on how to integrate COVID-19 vaccination into immunization, PHC and other health activities. It follows the Considerations for integrating...
This rotavirus-focused brief covers the economic costs of rotavirus disease and the value of vaccines.
Le programme de mise en œuvre de la vaccination antipaludique en Afrique
Depuis 2019, le vaccin est administré dans 3 pays par le biais de programmes nationaux de vaccination des enfants dans le...
The RTS,S/AS01 malaria vaccine. Significantly reduces malaria and life-threatening severe malaria. Since 2019, delivered in childhood vaccination in 3 country-led pilots.
An approach to optimize the global impact of COVID-19 vaccines at a time when Omicron and its sub-lineages are the dominant circulating variants of concern, based on public health goals, evolving...
This TechNet-21 webpage provides a package of tools and guidance to support programmes and partners to assess and address behavioural and social drivers (BeSD) of vaccination.
This TechNet-21 webpage provides a range of evidence-based guidance for programmes and partners to guide the implementation and evaluation of strategies to increase vaccine demand and uptake.
VIEW-hub is an easy to use repository for the most relevant and recent vaccine data, covering topics such as Vaccine Introduction & Use, Immunization Equity, Vaccine Preventable Disease Burden, and...
ROTA provides scientific and technical evidence to scientific authorities such as policymakers on rotavirus disease and vaccines.
The HPV Information Centre compiles, processes, and disseminates country-specific information related to HPV and cervical cancer to facilitate global, regional- and country-specific decisions on...
In accordance with its mandate to provide guidance to Member States on health policy matters, WHO publishes vaccine position papers providing global vaccine and immunization recommendations for...
Comparison table of WHO prequalified typhoid conjugate vaccines (TCVs).
These country-specific resources outline the burden of typhoid (provided by the Global Burden of Disease study) and the potential benefits of new typhoid conjugate vaccines in each country. They are...
This background document has been prepared by the SAGE working group on smallpox and monkeypox vaccines to inform the discussions of SAGE at its 3-7 October 2022 meeting.
Annexes to the Vaccines and immunization for monkeypox interim guidance
Estas recomendaciones provisionales1 se refieren a la vacuna mRNA-1273, fabricada por Moderna, que también se conoce como vacuna anti-COVID-19 de Moderna. En algunos países la vacuna se...
Le présent document remplace la précédente note de synthèse sur les vaccins anti-hépatite A, publiée par l’OMS en 2012. Il contient des recommandations sur l’utilisation hors indications de...
This document replaces the 2012 WHO position paper on hepatitis A vaccines. It contains off-label recommendations.
Recommandations provisoires concernant l’utilisation du vaccin de Valneva (VLA2001) contre la COVID-19 : orientations provisoires, première publication : 18 août 2022
Recomendaciones provisionales sobre el uso de la vacuna BNT162b2 de Pfizer y BioNTech contra la COVID-19 en el marco de la Lista OMS de uso en emergencias: orientaciones provisionales, primera...
The vaccine tracker was developed by World Bank in an effort to identify countries in urgent need of financial and operational support for vaccine deployment readiness, and to monitor, track and...
This is a link to a set of posts on vaccine introduction, supply chain and storage planning, and communication with communities,This is a link to a set of posts on vaccine introduction, supply chain...
This is a link to a post on how to generate demand for Covid-19 vaccination,This is a link to a post on how to generate demand for Covid-19 vaccination
This is Rockefeller microsite on Covid-19 vaccine particularly focusing on increasing demand and accelerating global equity,This is Rockefeller microsite on Covid-19 vaccine particularly focusing on...
Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention,Analyse de la réponse du...
RDC: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention
Guinée Bissau: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention pratiques...
Somalia: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans
Uganda: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans
Guinea Bissau: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans
South Sudan: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans
DRC: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans
Niger: Analyse de la réponse du pays à la COVID-19 et identification des meilleures pratiques et des lacunes cruciales à prendre en compte dans les futurs plans d’intervention
Mozambique: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans
Botswana: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans
Syria: Analysis of country COVID-19 response, identifying best practices and crucial gaps to factor into future response plans
This good practice statement has been developed based on the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 11 August 2022.
These are the annexes to the Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19.
This background document was prepared by the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines to inform the discussions of SAGE for Valneva vaccine...
This interim recommendation pertains to the COVID-19 Valneva vaccine (VLA2001), developed by Valneva’s research and development teams in France and Austria with the marketing authorization holder,...
This document explains why gender considerations matter for immunization programming with examples of common gender-related barriers, along with concrete gender-responsive approaches and actions that...
This guide breaks down the development of situation analysis into four well detailed sections.
1. Collection and gathering of data
2. Complete immunization coverage and equity...
This guide is designed to help anyone in the health and immunization system identify and address barriers or leverage drivers to immunization by locally codesigning and evaluating human-centred,...
This position paper discusses the development of the BeSD for vaccine tool. It covers the 4 phases and key activities for the development of the tool. They include:
• Initial development of the...
Behavioural and social drivers of vaccination Tools and practical guidance for achieving high uptake
The guide includes tools and guidance for understanding behavioural and social drivers of vaccination, as well as guidance on how to gather, analyse and use the resuting data. Furthermore, this...
The website provides the latest data availble at the WHO. It includes a wide range of data types and different presentations. Some of the featured data sets include: global health estimates,...
Nationally representative household survey that provides data for wide range of monitoring and impact evaluation indicators in the areas of population, health and nutrition.